Delveen R. Ibrahim
Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK
Ibrahim, Delveen R.; Dodd, Christine E. R.; Stekel, Dov J.; Meshioye, Remilekun T.; Diggle, Mathew; Lister, Michelle; Hobman, Jon L.
Authors
Christine E. R. Dodd
Professor DOV STEKEL DOV.STEKEL@NOTTINGHAM.AC.UK
PROFESSOR OF COMPUTATIONAL BIOLOGY
Remilekun T. Meshioye
Mathew Diggle
Michelle Lister
Dr JON HOBMAN jon.hobman@nottingham.ac.uk
ASSOCIATE PROFESSOR
Abstract
Globally, cephalosporin therapy failure is a serious problem for infection control. One causative agent of cephalosporin-resistant infections is multidrug-resistant (MDR) E. coli producing extended-spectrum β-lactamases (ESBLs) and/or plasmid-encoded AmpC (pAmpC) β-lactamases. We evaluated the occurrence of ESBL/pAmpC genetic determinants in phenotypically MDR E. coli isolated from clinical samples of blood, faeces, ear effusion, urine and sputum from a UK hospital. Phenotypic resistance profiling for 18 antibiotics (from seven classes) showed that 32/35 isolates were MDR, with resistance to 4–16 of the tested antibiotics. Of the isolates, 97.1% showed resistance to ampicillin, 71.4% showed resistance to co-amoxiclav, cefotaxime, ceftazidime and ceftiofur, and 68.5% showed resistance to cefquinome. blaCTX-M, blaTEM and blaOXA-1 genes were detected in 23, 13 and 12 strains, respectively, and Intl1 was detected in 17 isolates. The most common subtypes among the definite sequence types were CTX-M-15 (40%) and TEM-1 (75%). No E. coli isolates carried pAmpC genes. Significant correlations were seen between CTX-M carriage and cefotaxime, ceftiofur, aztreonam, ceftazidime and cefquinome resistance; between blaCTX-M, blaTEM and blaOXA-1 carriage and ciprofloxacin resistance; and between Intl1 carriage and trimethoprim/sulfamethoxazole resistance. Thus, MDR phenotypes may be conferred by a relatively small number of genes. The level and pattern of antibiotic resistance highlight the need for better antibiotic therapy guidelines, including reduced use and improved surveillance.
Citation
Ibrahim, D. R., Dodd, C. E. R., Stekel, D. J., Meshioye, R. T., Diggle, M., Lister, M., & Hobman, J. L. (2023). Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK. Antibiotics, 12(1), Article 169. https://doi.org/10.3390/antibiotics12010169
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 11, 2023 |
Online Publication Date | Jan 13, 2023 |
Publication Date | Jan 13, 2023 |
Deposit Date | Mar 17, 2023 |
Publicly Available Date | Mar 21, 2023 |
Journal | Antibiotics |
Electronic ISSN | 2079-6382 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Issue | 1 |
Article Number | 169 |
DOI | https://doi.org/10.3390/antibiotics12010169 |
Keywords | Escherichia coli; multidrug-resistant; cephalosporin-resistant; ESBL |
Public URL | https://nottingham-repository.worktribe.com/output/15940023 |
Publisher URL | https://www.mdpi.com/2079-6382/12/1/169 |
Files
Multidrug-Resistant ESBL
(2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search